AN
CelLBxHealth plc
ANPCY · OTC
$0.07 +0.00% (+$0.00)
Market Cap £1.63M
P/E Ratio -
Div. Yield -
ROE 104.73%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.14x
P/S 0.62x
EV/FFO N/A
Growth
61 /100
Stable Book val. growth 14.63%
Rev. growth 6.10%
FCF growth N/A
Profitability
20 /100
Weak Net margin 601.37%
Op. margin 627.67%
FCF margin 442.84%
Quality
2 /100
Poor ROE 104.73%
ROA 87.26%
Asset turnover 0.15x
Debt
80 /100
Low Current ratio 3.13x
Int. coverage -38.21x
Net debt/EBITDA 0.10x
Stability
42 /100
Moderate Rev. volatility 23.15%
EPS volatility 19.40%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ANPCY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Collins
Employees
119
Headquarters
Guildford